POLQ- and CtIP-regulated telomere fusions and translocations are involved in early events in carcinogenesis
POLQ 和 CtIP 调节的端粒融合和易位参与癌发生的早期事件
基本信息
- 批准号:10673149
- 负责人:
- 金额:$ 49.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAgingAneuploidyApplications GrantsAreaAwardBeliefBiologyBone marrow failureBypassC-terminalCancer BiologyCell DeathCell LineCell SurvivalCellsChromosomesCollaborationsComplementDNADNA Double Strand BreakDNA RepairDNA ligase IIIDNA-Directed DNA PolymeraseDataDiseaseDyskeratosis CongenitaEnsureEventExcisionFrequenciesGene MutationGene TargetingGenesGeneticGenomeGenomic InstabilityGoalsHumanInvestigationKnowledgeLaboratoriesLigaseMaintenanceMalignant NeoplasmsMediatingMedicineModelingMusMutationNobel PrizeNonhomologous DNA End JoiningNull LymphocytesOutcomePathologicPathway interactionsPhysiologyPlayPoly(ADP-ribose) PolymerasesPolymeraseProcessProductionProliferatingProteinsPublicationsRegulationResolutionRoleSister ChromatidStructureSyndromeSystemTechnologyTelomeraseTelomere MaintenanceTelomere ShorteningUltrafinecancer predispositioncarcinogenesiscell agecell transformationchromosome fusionchromothripsisexperimental studyloss of functionloss of function mutationmutantnovelnucleasepreventprogenitorrepairedresponsesenescencesingle moleculetelomeretumorigenesis
项目摘要
PROJECT SUMMARY
We propose to investigate the mechanisms that regulate a cell’s ability to escape from the crisis caused by
telomere shortening. As normal human cells age, their telomeres gradually shorten. When the telomeres
shorten significantly, the cell undergoes senescence, which is a naturally occurring barrier to cancer. If,
however, a cell should suffer a transforming mutation, it can by-pass senescence and continue to proliferate
until its telomeres become so short that they are non-functional. The resulting lack of end protection triggers
“crisis”, a state that is highlighted by genomic instability as chromosomes engage in breakage:fusion:bridging
cycles that almost invariably result in the death of the cell. On rare occasions a cell can resolve its fusions,
reestablish its telomeres and stabilize its genome. Such cells are said to be immortalized and it is likely that
they are the progenitors of most human cancers. That the (dys)regulation of telomere maintenance is also
associated with aging, immortalization, and tumorigenesis in other experimental systems adds confidence to
the belief that these issues are conserved and important. Previously, we have demonstrated that DNA ligase III
and poly (ADP) ribose polymerase 1 are required for human cells to survive crisis. Here, we propose to define
the role of DNA polymerase theta/Q (POLQ), which acts in the same pathway, in this process. Unexpectedly,
we show that deletion of POLQ causes telomere elongation and escape from crisis. We will uncover how
POLQ normally suppresses these events.
Integral to surviving crisis is a requirement to resolve the chromosomal fusions/translocations that occurred
during crisis. One way to do this is to physically shear them apart by the application of tension (aka,
“breakage”). This process, however, is highly mutagenic and often leads to lethal outcomes. A second
resolution process more likely to ensure survival is to convert the chromosome fusions into ultra-fine bridges
(UFBs) and then enzymatically — in a process that is very poorly understood — resolve these UFBs. Here, we
demonstrate that the loss-of-function of the resection nuclease, C-terminal interacting protein (CtIP), results in
a high frequency of UFBs that are not resolved and we propose experiments to mechanistically unravel how
these bridges, many of which involve telomeres, are generated and why they are not resolved. In all of these
approaches we utilize the strengths of the Hendrickson and Baird laboratories. The Hendrickson laboratory
excels at the technology of gene targeting to study the impact of loss-of-function mutations of genes (POLQ
and CtIP in this instance) on telomere maintenance. The Baird laboratory is the world’s leader in analyzing
telomere fusion events in human cells undergoing crisis. Their ability to characterize the dynamics of single
telomeric ends has provided the field’s deepest understanding of the mechanism of telomere fusions in human
cells. In summary, our proposed studies impact on DNA repair and telomere maintenance and the importance
of understanding these processes for cancer biology is clear.
项目总结
我们建议研究调节细胞逃脱危机能力的机制
端粒缩短。随着正常人类细胞的衰老,它们的端粒逐渐变短。当端粒
显著缩短的是,细胞经历衰老,这是一种自然产生的抗癌屏障。如果,
然而,细胞应该遭受转化突变,它可以绕过衰老,继续增殖。
直到它的端粒变得太短而不起作用。由此导致的终端保护不足引发了
“危机”,指染色体断裂时基因组不稳定的状态:融合:桥接
几乎总是导致细胞死亡的循环。在极少数情况下,细胞可以分解其融合,
重建其端粒并稳定其基因组。这种细胞据说是永生的,很可能是
它们是大多数人类癌症的始祖。端粒维持的(Dys)调节也是
在其他实验系统中与衰老、永生化和肿瘤形成相关的因素增加了信心
相信这些问题是保守的和重要的。此前,我们已经证明了DNA连接酶III
和聚(ADP)核糖聚合酶1是人类细胞在危机中生存所必需的。在这里,我们建议定义
DNA聚合酶theta/q(POLQ)在这一过程中的作用。出乎意料的是,
我们发现,POLQ的缺失会导致端粒延长并逃脱危机。我们将揭开如何
POLQ通常会抑制这些事件。
生存危机的一个组成部分是解决发生的染色体融合/易位的要求
在危机期间。这样做的一种方式是通过施加张力(又名,
“破损”)。然而,这一过程具有高度的诱变性,往往会导致致命的后果。一秒钟
更有可能确保生存的解决过程是将染色体融合转化为超精细的桥梁
(不明飞行物),然后酶法-在一个非常鲜为人知的过程-分解这些不明飞行物。在这里,我们
证明切除核酸酶C端相互作用蛋白(CtIP)的功能丧失会导致
高频率的未解决的不明飞行物,我们建议进行实验,以机械地解开
这些桥,其中许多涉及端粒,是产生的,以及为什么它们没有被解析。在所有这些中
我们利用亨德里克森和贝尔德实验室的优势。亨德里克森实验室
擅长基因打靶技术,研究基因功能丧失突变(POLQ)的影响
和在这种情况下的CtIP)。贝尔德实验室在分析方面处于世界领先地位
经历危机的人类细胞中的端粒融合事件。他们能够刻画单项运动的动态
端粒末端使该领域对人类端粒融合的机制有了最深入的了解
细胞。综上所述,我们提出的研究对DNA修复和端粒维持的影响及其重要性
对癌症生物学的这些过程的理解是显而易见的。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
ATRX modulates the escape from a telomere crisis.
- DOI:10.1371/journal.pgen.1010485
- 发表时间:2022-11
- 期刊:
- 影响因子:4.5
- 作者:
- 通讯作者:
POLQ suppresses genome instability and alterations in DNA repeat tract lengths.
- DOI:10.1093/narcan/zcac020
- 发表时间:2022-09
- 期刊:
- 影响因子:5.1
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ERIC A HENDRICKSON其他文献
ERIC A HENDRICKSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ERIC A HENDRICKSON', 18)}}的其他基金
POLQ- and CtIP-regulated telomere fusions and translocations are involved in early events in carcinogenesis
POLQ 和 CtIP 调节的端粒融合和易位参与癌发生的早期事件
- 批准号:
10770273 - 财政年份:2022
- 资助金额:
$ 49.95万 - 项目类别:
Ligase III regulates survival from crisis induced by gradual telomere shortening
连接酶 III 调节端粒逐渐缩短引起的危机中的生存
- 批准号:
9114537 - 财政年份:2015
- 资助金额:
$ 49.95万 - 项目类别:
Ligase III regulates survival from crisis induced by gradual telomere shortening
连接酶 III 调节端粒逐渐缩短引起的危机中的生存
- 批准号:
9308903 - 财政年份:2015
- 资助金额:
$ 49.95万 - 项目类别:
Ku regulates non-homologous end joining pathways in human somatic cells
Ku 调节人类体细胞中的非同源末端连接途径
- 批准号:
8298501 - 财政年份:2011
- 资助金额:
$ 49.95万 - 项目类别:
Ku regulates non-homologous end joining pathways in human somatic cells
Ku 调节人类体细胞中的非同源末端连接途径
- 批准号:
8527889 - 财政年份:2011
- 资助金额:
$ 49.95万 - 项目类别:
Ku regulates non-homologous end joining pathways in human somatic cells
Ku 调节人类体细胞中的非同源末端连接途径
- 批准号:
8658400 - 财政年份:2011
- 资助金额:
$ 49.95万 - 项目类别:
Ku regulates non-homologous end joining pathways in human somatic cells
Ku 调节人类体细胞中的非同源末端连接途径
- 批准号:
8820471 - 财政年份:2011
- 资助金额:
$ 49.95万 - 项目类别:
Ku regulates non-homologous end joining pathways in human somatic cells
Ku 调节人类体细胞中的非同源末端连接途径
- 批准号:
8193446 - 财政年份:2011
- 资助金额:
$ 49.95万 - 项目类别:
Ku regulates non-homologous end joining pathways in human somatic cells
Ku 调节人类体细胞中的非同源末端连接途径
- 批准号:
8649877 - 财政年份:2011
- 资助金额:
$ 49.95万 - 项目类别:
Ku regulates non-homologous end joining pathways in human somatic cells
Ku 调节人类体细胞中的非同源末端连接途径
- 批准号:
8460914 - 财政年份:2011
- 资助金额:
$ 49.95万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 49.95万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 49.95万 - 项目类别:
Collaborative R&D
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 49.95万 - 项目类别:
Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 49.95万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 49.95万 - 项目类别:
Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 49.95万 - 项目类别:
Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 49.95万 - 项目类别:
Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 49.95万 - 项目类别:
Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
- 批准号:
23K20355 - 财政年份:2024
- 资助金额:
$ 49.95万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
- 批准号:
23K24782 - 财政年份:2024
- 资助金额:
$ 49.95万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




